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SNAP25 and syntaxin-1 are core proteins of the exocytosis machinery for insulin granules. Takahashi et al.
(2010) show that the distribution and kinetics of the SNAP25/syntaxin-1 complex assembly play a key role
in regulating the first and second phase of insulin release.Pancreatic b cells produce and release
insulin, the key hormone for lowering
blood glucose levels. b cells store insulin
within granules, from which the hormone
is secreted extracellularly when glycemia
is >5.5 mM. Insulin release to a stepwise
glucose challenge occurs normally in
two phases: the first phase has a rapid
onset and is brief (2–5 min), while the sec-
ond lasts until fasting glycemia is restored
(usually <2 hr). Accordingly, inadequate
insulin supply relative to metabolic needs
causes hyperglycemia and diabetes mel-
litus. In type 2 diabetes, the first phase
of insulin release is reduced, and islets
from type 2 diabetic patients and the
Goto-Kakizaki rat, a model of type 2 dia-
betes, express lower levels of SNARE
(soluble N-ethylmaleimide-sensitive fac-
tor attachment protein receptor) proteins
(Nagamatsu et al., 1999; Ostenson et al.,
2006). In general, SNARE proteins are
either vesicle associated (v-SNAREs;
such as VAMP2/synaptobrevin-2) or tar-
get membrane bound (t-SNAREs; such
as syntaxin-1 and SNAP25). Formation
of a ternary complex between the cyto-
solic tails of v- and t-SNAREs drives
the juxtaposition and fusion of opposing
membranes—an essential process in all
eukaryotic cells that is often triggered by
an increase in free Ca2+ (Su¨dhof and
Rothman, 2009), as the fusion of insulin
granules with the plasma membrane.
In this issue of Cell Metabolism,
Takahashi et al. (2010) present data
regarding the kinetics of binary complex
formation between SNAP25 and syn-
taxin-1 (t-SNARE complex) in relationship
to granule exocytosis. They show that
membrane regions rich in preassembled
t-SNARE complexes are the preferred
sites for granule exocytosis immediatelyafter glucose stimulation. This remarkable
achievement was possible by measur-
ing fluorescence resonance energy trans-
fer (FRET) in mouse islets imaged with
two-photon laser scanning microscopy.
A FRET signal is generated when two fluo-
rescent dyes with overlapping spectra are
less than 10 nm apart. Takahashi et al.
developed a new FRET probe, termed
SLIM (SNAP25 reporter linker mutant), in
which the conformational change induced
by the binding of SNAP25 to syntaxin-1
reduces the distance between two
fluorochromes inserted within SNAP25,
thereby enhancing FRET. Notably, the
SLIM probe, unlike a similar construct
described previously (An and Almers,
2004), is insensitive to the interaction of
t-SNAREs to the v-SNARE VAMP2 on
the granules. This characteristic enabled
the authors to measure the kinetics and
distribution of t-SNARE assembly before
and after glucose stimulation by FRET,
while simultaneously monitoring granule
exocytosis by imaging the uptake of
an extracellular polar (membrane-imper-
meable) fluorescent tracer. Before stimu-
lation, the areas with low FRET signals,
interpreted as areas of unassembled
t-SNAREs, outnumbered those with
stable high FRET signals, i.e., assembled
t-SNAREs, 2:1, indicating that syntaxin-
1/SNAP25 complexes are unevenly dis-
tributed throughout the plasma mem-
brane. Exocytosis occurred preferentially
in high-FRET areas during the first phase
of glucose stimulation, whereas during
the second phase, it was equally frequent
in high- and low-FRET areas. Notably,
FRET values did not change during
exocytosis in high-FRET regions, but
increased3 s before detection of exocy-
tosis in low-FRET regions, suggesting thatCell Metabot-SNARE assembly is enhanced by glu-
cose stimulation and precedes exocy-
tosis. Overall, granule fusion was three
times more frequent in high-FRET areas
compared to low-FRET areas. Persis-
tence of maximal FRET values at exocy-
totic sites further suggests that SNAREs
neither diffuse nor immediately disas-
semble after granule fusion.
To gain insight into the kinetics of
t-SNAREcomplexassembly in relationship
toexocytosis, intracellularCa2+concentra-
tions ([Ca2+]i) were rapidly increasedbyun-
caging a caged-Ca2+ compound.With this
increase in [Ca2+]i, the time constant for
induction of exocytosis was 1 s in high-
FRET areas, whereas in low-FRET areas,
the increases of FRET values had a latency
of10 s andprecededexocytosis by3 s.
These data strengthen the conclusion that
t-SNARE assembly is a prerequisite for
exocytosis, its preassembly prior to stimu-
lation being key for the first phase of insulin
secretion and its assembly after stimula-
tion being the rate-limiting step for the
second phase.
Previous studies showed clustering of
SNARE proteins in discrete membrane
areas in neuroendocrine cells (Lang
et al., 2001), including b cells, where they
are the preferred sites of granule exocy-
tosis (Ohara-Imaizumi et al., 2007). Strik-
ingly, the latter study found that neither
syntaxin-1A nor other syntaxins were
involved in the second phase of insulin
secretion. Hence, a lower expression of
syntaxin-1 in type 2 diabetic islets could
account for their impaired first phase of
insulin release. This scenario is at odds
with the new data by the Kasai group,
unless it is assumed that SNAP25 forms
fusion complexes with proteins other
thansyntaxinsandVAMP2—apropositionlism 12, July 7, 2010 ª2010 Elsevier Inc. 5
Figure 1. Reduced t-SNARE Complex Preassembly as a Possible
Mechanism for Secretion Deficit in Diabetic b Cells
The graphic illustrates the distribution of unassembled t-SNARE proteins
SNAP25 and syntaxin-1 and preassembled SNAP25/syntaxin-1 complexes
(white shaded area) in the plasma membrane of b cells in physiological condi-
tions (top panel) and in the context of type 2 diabetes (lower panel). Lower
expression of t-SNAREs and alterations of the membrane lipid composition
occurring in type 2 diabetes could lead to fewer preassembled t-SNARE
complexes and thereby to the loss of the first phase of insulin release—a char-
acteristic phenotypic alteration of the disease.
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then be that the critical factor
leading to the selective deficit
of insulin secretion in type 2
diabetes is a decrease in
the number of preassembled
t-SNARE complexes (Fig-
ure 1)? This hypothesis could
be readily tested by employ-
ing SLIM to investigate
t-SNARE assembly in b cells
of type 2 diabetic patients
and the Goto-Kakizaki rat.
Preassembled t-SNAREcom-
plexes could be reduced in
diabetic b cells due to various
factors, including the lower
expression of SNARE pro-
teins, but also alterations
of membrane lipid microdo-
mains. t-SNARE proteins
and interacting ion channels
such as CaV1.2 and KV2.1
have been shown to preferen-
tially partition in cholesterol-
rich membrane areas (Xia
et al., 2004). The high levels
of circulating free fatty acidcommonly found in diabetic patients
could perturb this protein-lipid order.
The new data by Takahashi et al.
provide valuable insight into parts of the
kinetics regulating exocytosis, but leave
open numerous questions. According to
the prevailing model, the first phase of
insulin release is mainly due to the exocy-
tosis of granules that, prior to glucose
stimulation, reside in direct contact with
the cell membrane (‘‘docked granules’’)
and are competent for fusion (‘‘primed
granules’’). The second phase, instead,
reflects the exocytosis of granules that
are recruited from intracellular stores to
the plasma membrane at a later time
(Rorsman and Renstro¨m, 2003). Evidence
also suggests, however, that granules
newly approaching the plasma mem-
brane also contribute to the first phase
(Shibasaki et al., 2007). Therefore, it will
be important to clarify the spatial and
temporal relationship of these various
granule pools with the assembly states
of t-SNAREs and SNAREs in general. To6 Cell Metabolism 12, July 7, 2010 ª2010 Elsthis aim, additional FRET probes for the
v-SNARE VAMP2 could be used. Cargo
peptides of insulin granules can also be
fluorescently labeled. This approach, in
particular, can ensure the exclusive
imaging of insulin granule trafficking and
exocytosis in b cells. It might also allow
for elucidating whether the observed
different kinetics for exocytosis between
high-FRET (1 s) and low-FRET (3 s)
areas after stimulation and complex
assembly reflects the time necessary for
granules to dock and/or be primed for
fusion. Finally, the use of fluorescence
lifetime imaging microscopy (FLIM),
a FRET technique that is unaffected by
probe concentrations, tissue light scat-
tering, or the emission light path, and the
application of super-resolution micros-
copy could further improve the analysis
of t-SNARE complex assembly (Rickman
et al., 2010). As elegantly shown here by
Takahashi and coworkers, new bright
ideas and tools are bringing us ever closer
to untangling complex matters such asevier Inc.insulin secretion and, hope-
fully, the reason for its deficit
in type 2 diabetes.
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